In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often c…
GenSight Biologics becomes first gene therapy company listed in Europe
GenSight Biologics has become the first gene therapy company to be listed in Europe following an initial public offering on Euronext Paris, according to company correspondence.GenSight, founded in 2012 and based in Paris, focuses on the discovery and d…
Buprenorphine implants could be effective option to treat adults with opioid dependence
While buprenorphine has long been used to treat adults with opioid dependence, its efficacy can be hindered by lack of adherence to daily, sublingual (beneath the tongue) doses of the medication.
In memory of Prof. Kazuichi Konyama, 1928 to 2016
It is with great sadness that we announce the passing of Prof. Kazuichi Konyama, a great leader and mentor of ophthalmology in Japan and Thailand and around the Asia-Pacific region.Although Prof. Konyama was born in Kagawa, Japan, he began his medical training in Thailand in the 1950s. In 1960, he received a doctorate from Juntendo University in Tokyo, where he was later an instructor. He also completed a master’s degree in public health from Johns Hopkins University in 1982.
OphthoBook Questions
Here’s my latest book … hope it’s not too silly for you! You can buy OphthoBook questions at:
https://www.amazon.com/OphthoBook-Questions-Vol-1/dp/1533539715 |
Views:
5913 104
ratings |
|
Time: 05:29 |
More in Education |
Santen to acquire InnFocus
Santen Pharmaceutical announced it has entered into a definitive agreement to acquire InnFocus, developer of the MicroShunt glaucoma implant device.Santen will acquire InnFocus for an upfront payment of $225 million, plus performance-based consideratio…